Flexible, Responsive Capital

R. Bryan Jadot is Head of Life Sciences Venture Lending and brings nearly 20 years of financial and credit structuring experience to Hercules. Prior to joining Hercules in 2005, Jadot served as vice president of the Life Sciences Group at Silicon Valley Bank (SVB) in Newton, MA where he co-managed a banking group dedicated to New England-based life science clients including biotechnology, medical device, and healthcare IT clients. Jadot also worked as the vice president of the Software Group at Silicon Valley Bank in Palo Alto, CA. Prior to Silicon Valley Bank, Jadot worked with the Corporate Banking arm of the Banque Nationale de Paris (BNP) in San Francisco, CA and was an assistant economist with the Department of Treasury’s Office of Eastern Europe and former Soviet Union in Washington DC. Jadot earned a B.A. in economics and government from California State University at Sacramento, and completed the Wells Fargo Bank Credit Management Training Program. He served as a nuclear operations specialist with the US Army (Europe) and is fluent in French.

• Call
• Email

Mike Dutra is a Managing Director and Senior Investment Officer in the Life Sciences Group working in the Boston office. He is focused on transactions with a broad range of private and public healthcare companies including biotechnology, specialty pharmaceuticals, medical device, innovative services, and other healthcare companies at all stages of development. Mike joined Hercules in June 2014 and was most recently promoted to Managing Director in January 2021. Prior to Hercules, he held positions with Goldman Sachs as an Operations Analyst and with DePuy Synthes as a Quality Engineer. Mike graduated with honors from Northeastern University with a B.S. in Industrial Engineering.  

• Call
• Email

A managing director in the Life Sciences Group, Janice has more than 25 years of life science experience and focuses on emerging growth stage life science companies. Before joining Hercules in 2010, Janice managed strategic corporate investor fundraising for Commons Capital and Oxford Bioscience Partners to create a global health fund focused on innovative healthcare investments for emerging and developing countries. Before that, she was Senior Vice President and group head-life sciences for Comerica. Janice also led the Massachusetts Biotechnology Council, the first biotechnology association in the world, for 12 years as President/CEO. Janice also held several other senior managerial positions, including CFO/controller of Cambridge Medical Technology Corporation, senior public accountant for Coopers & Lybrand Emerging and Middle Market Group, and project manager for NASA Space Science at UNH. She currently serves on the board of directors of the MIT Koch Institute for Integrative Cancer Research and The Village Bank, as an advisor to TBS Technologies, co-President of the Crystal Lake Conservancy and a member of the Women’s Forum. She has also been named as one of Boston Magazine’s 100 most influential women. Janice holds an M.B.A in finance and accounting and Bachelor of Science in veterinary science from the University of New Hampshire.

• Call
• Email

Lake McGuire is Managing Director responsible for business development in the life sciences and broader healthcare market. He is a seasoned executive, with more than 10 years of experience in the middle-market and venture debt markets, focused on structuring financial transactions for life sciences and technology related companies. Most recently, Mr. McGuire served as Vice President, Business Development at Comerica Bank, and was responsible for business development in the life sciences and technology markets. He has served in various roles in the Technology and Life Sciences and the Middle-Market Divisions during his 10-year tenure at Comerica Bank. Mr. McGuire received a Bachelor of Science in Construction Management from Michigan State University and a Master of Business Administration in Finance from the University of Michigan.

• Call
• Email

Cristy Barnes is a Managing Director in Hercules’ Life Sciences Group. Cristy brings to Hercules over 25 years of investing experience working in both the private and public equity markets. Most recently, Cristy served as Managing Director at Lighthouse Capital Partners, a leading venture debt firm, where she led the fund’s healthcare efforts, focusing primarily on VC-backed biotech and medical device opportunities. While at Lighthouse, Cristy sourced, structured and negotiated 70 loan transactions providing $455 million in commitments to promising growth-oriented businesses. Prior to joining Lighthouse, Cristy was a Senior Associate at Highland Capital Partners, where she worked on west coast technology venture capital investments.  Before Highland, Cristy spent five years at Robertson Stephens and Company in the Technology Research Group. Cristy holds a BA in Psychology with a minor in Business from the University of California, Los Angeles.

• Call
• Email

Michael is a Managing Director, Portfolio Management and currently focuses on debt and equity investments in the Life Science and Technology sectors. Michael joined Hercules Capital as an Analyst Intern in January 2007 and was promoted to the role of Associate in October 2009. Michael was promoted to Vice President in April 2011 and then to Managing Director, Portfolio Management in January 2019. Prior to Hercules, he held positions with Credit Suisse HOLT as an equity research analyst and with Bristol-Myers Squibb as a global sourcing and supplier management analyst. Michael graduated from Northeastern University with a B.S. in Finance.

• Call
• Email

Tom Hertzberg is a Managing Director responsible for business development in the life sciences and broader healthcare market, including sourcing and executing investment opportunities. Prior to joining Hercules Capital, Tom spent 15 years in a variety of roles at Silicon Valley Bank including sales and portfolio leadership positions. Most recently, Tom led a team within SVB’s Life Sciences and Healthcare practice, overseeing coverage of 24 states and 700 client relationships. Over his career, he has deployed several billion dollars of debt capital across a broad range of private and public technology and healthcare companies. He’s also a member of the Finance Committee for the Colorado Bioscience Association, which provides networking and development opportunities to professionals in Colorado’s thriving bioscience sector. Tom graduated with a BSBA from the University of Denver.

• Call
• Email

Adam Soller is a Managing Director in the Life Sciences group working in the greater Washington, DC region. He has over 20 years of senior lending experience, with 17 of them in the life sciences industry. Prior to Hercules, Adam was a Managing Director at Oxford Finance. During his time at Oxford he originated, structured and underwrote nearly $3 billion in debt facilities for life sciences and healthcare companies. He was also responsible for originations in Australia, Europe, Israel and a majority of the United States. Prior to joining Oxford, Adam was an Analyst in the Acquisitions Group of Capital Automotive, a real estate investment trust, where he underwrote over $1 billion in transactions and managed a portion of a $2.5 billion portfolio. Adam holds a B.A. in economics and business, with a concentration in financial management from the Virginia Military Institute.

• Call
• Email

Jeffrey joined Hercules in September 2021 and is a Principal in the Life Sciences Group working in the Boston office. From 2016 to 2021, Jeff was a Director and Vice President in the Healthcare Sponsor Finance group at Silicon Valley Bank where he underwrote and managed senior secured financings for private equity backed healthcare services and healthcare IT companies. Jeff was previously an Analyst and Associate at Hercules, supporting the Life Sciences and Technology groups.

Jeff graduated with honors from Northeastern University with a B.S. in Finance and is a CFA charterholder.

   

• Call
• Email

John Miotti is a Principal in the Life Sciences Group working in the New York office. He underwrites investments to a broad range of healthcare companies, including biotechnology, healthtech, med device, and value-based care. John joined Hercules as an Analyst in January 2017 and was most recently promoted to Principal in January 2023. John graduated cum laude from Boston College with a B.A. in both Economics and English.    

• Call
• Email

Brian Powers joined Hercules in 2023 and is a Principal responsible for business development, sourcing, and executing investment opportunities in the healthcare services and life sciences market. Prior to joining Hercules Capital, Brian spent 10 years in a variety of roles at Silicon Valley Bank, most recently as a Director within SVB’s Life Sciences and Healthcare practice, overseeing a team responsible for providing debt capital across a broad range of private and public technology and healthcare companies. Brian graduated from the University of Iowa with a B.S. in Finance and was a member of 2004 Co-Big 10 Champion Football Team. He is also a CFA charterholder.

• Call
• Email